Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma

Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma

Background: EGFR mutation is a common oncogene driver in East Asians with lung adenocarcinoma (LUAD), conferring a favorable prognosis with effective targeted therapy. However, the EGFR mutation is a weak predictor of long-term survival. Therefore, a powerful predictive tool is urgently needed to es...

Full description

Bibliographic Details
Main Authors:	Chengming Liu, Sufei Zheng, Sihui Wang, Xinfeng Wang, Xiaoli Feng, Nan Sun, Jie He
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-04-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359211006949

Similar Items

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
by: Chengming Liu, et al.
Published: (2021-08-01)

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
by: Runsen Jin, et al.
Published: (2020-08-01)

Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations
by: Geng Y, et al.
Published: (2020-10-01)

EGFR and KRAS mutation coexistence in lung adenocarcinomas
by: Vitor Manuel Leitão de Sousa, et al.
Published: (2015-04-01)

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
by: Zhang R, et al.
Published: (2016-01-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
by: Chun-Yu Lin, et al.
Published: (2017-01-01)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
by: Fu-Tsai Chung, et al.
Published: (2015-01-01)

DOK2 inhibits EGFR-mutated lung adenocarcinoma.
by: Alice H Berger, et al.
Published: (2013-01-01)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.
by: Jaeyoung Cho, et al.
Published: (2016-01-01)

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients
by: Li SHAN, et al.
Published: (2013-02-01)

The prognostic implications of EGFR mutation and ALK rearrangement for the long‐term outcomes of patients with resected lung adenocarcinomas
by: Hyungjin Kim, et al.
Published: (2019-07-01)

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.
by: Chenguang Li, et al.
Published: (2011-01-01)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
by: Xu H, et al.
Published: (2020-08-01)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
by: Liang Shi, et al.
Published: (2021-03-01)

Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
by: Toshihide Nishimura, et al.
Published: (2020-08-01)

The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma
by: Ismail Beypinar, et al.
Published: (2019-08-01)

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis
by: Yajuan Cao, et al.
Published: (2019-01-01)

Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs
by: Tzu-Hsuan Chiu, et al.
Published: (2021-09-01)

MET-EGFR dimerisation in lung adenocarcinoma is dependent on EGFR mutations and altered by MET kinase inhibition
by: Lee, Richard William
Published: (2017)

Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis
by: Limin CHEN, et al.
Published: (2019-05-01)

Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
by: Rong Jiang, et al.
Published: (2016-01-01)

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma
by: Ping HE, et al.
Published: (2013-10-01)

The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.
by: Wan Shanzhi, et al.
Published: (2014-01-01)

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
by: Mao Y, et al.
Published: (2017-07-01)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
by: Roberto Chalela, et al.
Published: (2019-04-01)

Relationship between EGFR Mutations and Pathological Classification and  Specimen of Lung Adenocarcinoma
by: Lifei KANG, et al.
Published: (2017-06-01)

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
by: Eric Dansin, et al.
Published: (2015-03-01)

Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas
by: Wu Shafei, et al.
Published: (2010-07-01)

Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations
by: Ji Young Park, et al.
Published: (2019-06-01)

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma
by: Jia-Wei Luo, et al.
Published: (2021-01-01)

Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation  in Advanced Lung Adenocarcinoma
by: Yutao LIU, et al.
Published: (2014-05-01)

Adenocarcinoma of the lung with EGFR gene mutation and subsequent resistance mechanisms exploration: case report
by: Xu L, et al.
Published: (2017-09-01)

Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
by: Mai Matsumura, et al.
Published: (2019-01-01)

Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
by: Zheng H, et al.
Published: (2019-07-01)

Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma
by: Xiaowei Qiu, et al.
Published: (2019-02-01)

Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities
by: Wai-Kok Choong, et al.
Published: (2021-06-01)

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
by: Jiang-Yong Yu, et al.
Published: (2016-03-01)

Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.
by: Jeng-Sen Tseng, et al.
Published: (2014-01-01)

Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations
by: Zhang Y, et al.
Published: (2021-04-01)